The decision not to provide the 2022 401(k) company match and pause merit increases was necessary due to our company performance in 2022. We simply didn’t have the financial performance in 2022 to support those investments. These are not actions that we wanted to take, and we understand the impact on each of you, especially in a time of high inflation.
These actions are not intended to be permanent, and we have turned out attention to the future. As highlighted during the Town Hall, we are working on the launch of a true merit increase approach based on shared goals and individual performance. Our goal is to provide visibility to this new structure in July. I know that or team members would like to know when under this new structure increases will be provided. If business performance has improved in terms of growth and we can get some relief in terms of the inflationary environment, we may be in the position to get back to providing increases in Q4. We will provide updates as we monitor the situation. In terms of the 401(k) company match, we are accruing funds for a potential 2023 company match.
As it relates to other investments in our team members, we will continue to invest in leadership training, people development programs, incentives for earning more certifications and licenses, and tuition reimbursement. We will also continue to hire people based on business needs. There is no hiring freeze; we must have the right people in the necessary roles to deliver quality clinical services.
We’ve been fortunate to have long periods of growth and economic stability and we are equally fortunate that we have the discipline and foresight to weather economic curve balls and a maturing industry in a way that our competitors have not. We’ve come through the pandemic, and we are turning the corner on a business environment that has challenged us in unfamiliar ways. We remain fully dedicated to the BHG 3.0 mission, our patients, and you.
Russell Goin
Chief People Officer, BHG